Article Text

Download PDFPDF
CASE REPORT
A unique case of nephrogenic systemic fibrosis from gadolinium exposure in a patient with normal eGFR
  1. Sadichhya Lohani1,
  2. Jon Golenbiewski1,
  3. Abhishek Swami1,2,
  4. Alexandra Halalau1,3
  1. 1Department of Internal Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA
  2. 2Department of Nephrology, William Beaumont Hospital, Royal Oak, Michigan, USA
  3. 3Oakland University, William Beaumont School of Medicine, Rochester, Michigan, USA
  1. Correspondence to Dr Sadichhya Lohani, sadichhya.lohani{at}gmail.com

Summary

A 57-year-old woman presented with swelling and thickening of the skin of the lower extremities. Three months prior to presentation, patient had MRI with gadolinium as part of an evaluation for suspected pancreatic malignancy. Creatinine levels at the time of gadolinium exposure were 0.9–1.2 mg/dL, with a corresponding estimated glomerular filtration rate of 64 mL/min/1.73m2 by modification of diet in renal disease equation. Twenty-four-hour urine creatinine clearance was performed as an outpatient following development of symptoms. This revealed a creatinine clearance of 23 mL/min, suggestive of advanced chronic kidney disease despite an estimated glomerular filtration rate of 64 mL/min/1.73m2. Skin biopsy was positive for sclerosing dermopathy. These findings, in addition to the temporal association with gadolinium exposure, led to the diagnosis of nephrogenic systemic fibrosis.

  • dermatology
  • contraindications and precautions
  • renal system
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors SL, JG, AS and AH have substantially contributed to the intellectual content and design of the manuscript including acquisition, interpretation of the data, drafting, and revision of the manuscript. All coauthors agree to be accountable for all aspects of the manuscript and questions related to accuracy and integrity of any part of the manuscript. We assure that all the authors included in the paper fulfill the criteria of authorship. We also assure that there is no one else who fulfills the criteria that have been excluded as an author. SL: designing of the manuscript including the content, drafting, data acquisition, analysis and revision. JG: designing, data acquisition, and revision. AS: intellectual content, revision, data acquisition and interpretation. AH: designing, planning, drafting, intellectual content and revision.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.